Reported Dec 9, 2020 · Terminated

Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex Pharmceuticals, Inc.…

InvaTech Pharma Solutions, LLC

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: InvaTech Pharma Solutions, LLC · 40c Cotters Ln Ste A · East Brunswick, NJ · 08816-2037

Is this the product you have?

  • Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only
  • Distributed byMarlex Pharmceuticals, Inc. New Castle, DE 19720. NDC 10135-0639-30
Lot codes and dates
    • Lot #: 051944A Exp. Date April - 2021
    • 1119124 Exp Date Oct - 2021
    • 062088 Exp Date June - 2022
Amount recalled
N/A

Where it was sold

  • Nationwide

Why it was recalled

Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing.

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new InvaTech Pharma Solutions, LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Jun 20, 2023 · Data as of Sep 19, 6:38 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.